Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,288
Closed -$2.56M – 189
2026
Q2
$2.56M Buy
1,288
+196
+18% +$312K 0.53% 50
2026
Q1
$1.44M Buy
+1,092
New +$1.5M 0.37% 64

Other funds holding ASML

Cadent Capital Advisors's ASML Position: Q3 2026 in Review

Cadent Capital Advisors sold out of ASML (ASML) in Q3 2026, closing a stake of 1,288 shares — an estimated $2.56M sold.

Cadent Capital Advisors first reported a position in ASML in Q1 2026 and held it in 2 quarters. The position peaked at $2.56M in Q2 2026. 118 funds tracked by Wall St. Rank hold ASML as of Q3 2026.

  • Cadent Capital Advisors reported no remaining ASML position as of Q3 2026 after selling out during the quarter.
  • Cadent Capital Advisors sold 1,288 ASML shares in Q3 2026, an estimated $2.56M.
  • Cadent Capital Advisors first reported a position in ASML in Q1 2026 and held it in 2 quarters.
  • Cadent Capital Advisors's ASML position peaked at $2.56M in Q2 2026.
  • 118 funds tracked by Wall St. Rank held ASML as of Q3 2026.

Based on Cadent Capital Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.